The Riverside Company, a private equity firm, completed the investment in Avance Clinical, a provider of contract research services intended for pharmaceutical and biotechnology companies. Financial terms were not disclosed. “With the support of Riverside and its powerful global footprint and deep healthcare experience, Avance Clinical will execute on its regional and international expansion plans organically and via acquisitions," Yvonne Lungershausen, Avance Clinical CEO.